The regenerative medicine sector has long promised transformative therapeutic interventions, yet commercial viability remained elusive for decades. Recent developments suggest the field has reached a critical inflection point where cellular therapy technologies transition from experimental protocols to scalable clinical applications. Companies like Celljevity, with their Prometheus Cell therapy demonstrating consistentContinue Reading